Emmaus Life Sciences, Inc. (MYND) [Rocket]

Overview

Emmaus Life Sciences, Inc. (MYND)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Price:	$6.55			Metrics
OS:	53.6	M
Market cap:	$351	M
Net debt:	$16.4	M
EV:	$368	M

TTM Valuation
EBITDA
EBIT	($1.2)	M
EPS	($0.03)

Recent News + Filings (All items)

Date Filed	Type	Description
10/04/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/23/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/14/2023	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
06/02/2023	4	LEE WILLIS C (COO) has filed a Form 4 on Emmaus Life Sciences, Inc.
05/15/2023	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
03/31/2023	8-K	Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Sep-30-18	Sep-30-17	Sep-30-16
Revenues	18.4	20.6	23.2	22.8	16.5	1.3	0.1	0.1
Revenue growth	-10.8%	-11.0%	1.8%	38.2%		923.7%	22.3%	5.0%
Cost of goods sold	2.6	3.3	2.2	1.1	1.0	0.8	0.1	0.0
Gross profit	15.8	17.3	20.9	21.7	15.5	0.5	0.1	0.1
Gross margin	85.9%	83.9%	90.3%	95.2%	94.0%	37.1%	58.4%	94.8%
Sales and marketing	7.5	5.9	4.9	7.0	4.7	1.6	1.2	0.5
Research and development	1.7	4.1	2.4	2.2	1.7	1.1	1.2	0.7
General and administrative	13.2	13.4	13.7	17.0	17.5	7.7	4.6	2.5
EBIT	-8.5	-8.9	-2.1	-4.9	-8.6	-10.2	-7.1	-4.0
EBIT margin	-46.2%	-43.0%	-9.0%	-21.7%	-52.0%	-778.8%	-5528.1%	-3845.7%
Pre-tax income	-10.6	-15.9	1.0	-54.7	-72.5	-10.3	-7.1	-5.9
Income taxes	0.1	0.0	-0.4	0.2	0.0	0.0	0.0	0.0
Net income	-10.6	-15.9	1.4	-54.8	-72.6	-9.6	-7.1	-5.9
Net margin	-57.6%	-77.4%	5.8%	-240.9%	-441.0%	-729.7%	-5535.3%	-5652.6%

Diluted EPS	($0.21)	($0.32)	$27.69	($1.30)	($1.97)	($1.85)	($2.52)	($9.26)
Shares outstanding (diluted)	49.4	49.3	0.0	42.3	36.9	5.2	2.8	0.6

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy